Legend Biotech (LEGN) Return on Equity (2020 - 2025)

Legend Biotech (LEGN) has 6 years of Return on Equity data on file, last reported at 0.0% in Q1 2025.

• In Q1 2025, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2025 stood at 0.0% (changed 0.0% YoY), while the FY2024 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Equity fell to 0.0% in Q1 2025, from 0.0% in the prior quarter.
• Across five years, Return on Equity topped out at 0.0% in Q4 2024 and bottomed at 17.11% in Q2 2021.
• A 5-year average of 1.23% and a median of 0.0% in 2022 frame the typical range for Return on Equity.
• Annual changes were most pronounced in 2021 — Return on Equity jumped 837 bps — and 2023, when it changed 0 bps.
• Year by year, Return on Equity stood at 0.01% in 2021, then grew by 27 bps to 0.0% in 2022, then grew by 9 bps to 0.0% in 2023, then surged by 95 bps to 0.0% in 2024, then sank by 845 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q1 2025), 0.0% (Q4 2024), and 0.0% (Q3 2024), per Business Quant data.

Peer Comparison